The Yellow Card Scheme: Patient Reporting of Adverse Drug Reactions and Signals they have Generated

被引：0

作者：

Foy, M. ^{[1
]}

Gandhi, S. ^{[1
]}

Suri, S. ^{[1
]}

Cumber, S. ^{[1
]}

Jadeja, M. M. ^{[1
]}

机构：

[1] Med & Healthcare Prod Regulatory Agcy, London, England

来源：

DRUG SAFETY | 2011年 / 34卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：903 / 903

页数：1

共 50 条

[41] REPORTING ADVERSE DRUG REACTIONS
不详
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 196 (05): : 429 - &
[42] Reporting of adverse drug reactions
Davies, Heather
Noble, P. J.
Pinchbeck, Gina
Killick, David
[J]. VETERINARY RECORD, 2019, 185 (14)
[43] Microchip adverse reactions reporting scheme
Swift, S
[J]. JOURNAL OF SMALL ANIMAL PRACTICE, 1997, 38 (08) : 370 - 370
[44] INHERENT LIMITATIONS OF THE YELLOW CARD SYSTEM FOR THE DETECTION OF UNSUSPECTED ADVERSE DRUG-REACTIONS
CROMBIE, I
[J]. HUMAN TOXICOLOGY, 1984, 3 (04): : 261 - 269
[45] The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective
Anderson, Claire
Krska, Janet
Murphy, Elizabeth
Avery, Anthony
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (05) : 806 - 822
[46] UK's MHRA encourages Yellow Card Scheme reporting
[J]. Reactions Weekly, 2018, 1701 (1) : 8 - 8
[47] UK's MHRA Encourages Yellow Card Scheme Reporting
不详
[J]. PHARMACEUTICAL MEDICINE, 2018, 32 (04) : 305 - 305
[48] Patient safety and reporting of spontaneous adverse drug reactions in paediatric inpatients
Kakosova, V.
[J]. PHARMACY WORLD & SCIENCE, 2010, 32 (05): : 685 - 685
[49] Stimulating Spontaneous Reporting of Adverse Drug Reactions by a Patient: Directed Incentive
Slobodan M. Jankovic
[J]. Drug Safety, 2003, 26 : 741 - 742
[50] Factors affecting patient reporting of adverse drug reactions: a systematic review
Al Dweik, Rania
Stacey, Dawn
Kohen, Dafna
Yaya, Sanni
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (04) : 875 - 883

← 1 2 3 4 5 →